CymitQuimica logo

N-(2-Chloro-4-methylphenyl)-4,5-dihydro-1H-imidazol-2-amine

CAS:

Ref. 3D-EAA20122

50mg
456.00€
500mg
1,085.00€
N-(2-Chloro-4-methylphenyl)-4,5-dihydro-1H-imidazol-2-amine
Biosynth

Product Information

Name:N-(2-Chloro-4-methylphenyl)-4,5-dihydro-1H-imidazol-2-amine
Brand:Biosynth
Description:2-Chloro-4-methylphenyl-N-(2-chloro-4-methylphenyl)-4,5-dihydroimidazol-2amine is a potent immunosuppressive drug. It has been shown to be effective in the treatment of autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus. The drug has been found to be safe and effective in animal models of cardiac disease. 2C4MPI is an analog of azathioprine, which is used for the treatment of inflammatory and autoimmune diseases. In addition, this drug has been shown to have antihyperglycemic properties by inhibiting glucose production in the liver and increasing insulin sensitivity in muscle tissue. 2C4MPI also reduces collagen synthesis, which may be useful in treating inflammatory diseases that are caused by excess collagen deposition such as skin conditions like psoriasis or acne vulgaris.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:209.67 g/mol
Formula:C10H12ClN3
Purity:Min. 95%

Technical inquiry about: N-(2-Chloro-4-methylphenyl)-4,5-dihydro-1H-imidazol-2-amine

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.